Dauerman / Sobel Pharmacoinvasive Therapy in Acute Myocardial Infarction

Erscheinungsjahr 2005
ISBN: 978-0-8493-4055-0
Verlag: Taylor & Francis
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 264 Seiten

Reihe: Fundamental and Clinical Cardiology

This reference collects the latest scientific evidence illustrating the increasing importance of pharmacoinvasive therapy in the treatment of ST elevation acute myocardial infarction-tracking the origins, evolution, and limitations of current treatment methods and highlighting new clinical trial data showcasing the potential of the combined treatment approach and controversial issues surrounding this emerging therapeutic modality.

Zielgruppe

Cardiologists, thrombocardiologists, cardiovascular and thoracic surgeons, internists, hematologists, physiologists, epidemiologists, emergency medicine physicians, and fellows and medical school students in these disciplines.

Autoren/Hrsg.

Dauerman, Harold L.

Sobel, Burton E.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie

Inhaltsverzeichnis

Approaches to Reperfusion in the Treatment of STEMI: Thrombolysis or Primary PCI. Development, Impact, and Limitations of Coronary Thrombolysis. Development, Impact, and Limitations of Primary PCI in the Treatment of STEMI. The Evolution of Combination Therapy-Thrombolysis and PCI. Complications and Diminishing Enthusiasm after Initial Trials Combining Thrombolysis with Prompt Mechanical Coronary Intervention in the Treatment of STEMI. Amalgamation of Coronary Thrombolysis and PCI Revisited. Definitive Assessment of Pharmacoinvasive Therapy in the Treatment of STEMI. Design and Overview of Contemporary Studies of Pharmacoinvasive Therapy. Considerations in Treatment of Elderly Patients with STEMI. Controversy and Clarification